Abstract
In seven patients suffering from inoperable pancreatic cancer and in 14 patients with inoperable colonic cancer the half-life (T/2) of prostaglandin (PG)I2 in plasma in vitro has been determined before and at various intervals after irradiation. No significant difference of PGI2-T/2 could be observed either before irradiation, at the end of the irradiation period or 3 and 6 weeks after the last irradiation. Thus irradiation does not appear to interfere with the degradation of PGI2-T/2 in plasma. In patients with inoperable pancreatic and colonic cancer the PGI2-T/2 was not significantly different to that of the PGI2-T/2 of controls. Thus, a shortening of PGI2-T/2 is not a common feature in tumour patients. Hyperaggregation promoting seeding of metastases is not influenced by irradiation via the particular parameter of the PG-system.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Benedetto C., Barbero M., Rey L., Petitti E., Baccarini G., Ghiringhello B., Massobrio M., Slater T. F. Production of prostacyclin (PGI2) and thromboxane A2 (TXA2) by vessels draining and not-draining benign and malignant tumours of the breast. Prostaglandins Leukot Med. 1985 Jan;17(1):31–42. doi: 10.1016/0262-1746(85)90031-9. [DOI] [PubMed] [Google Scholar]
- Defreyn G., Dauden M. V., Machin S. J., Vermylen J. A plasma factor in uraemia which stimulates prostacyclin release from cultured endothelial cells. 1980 Aug 15-Sep 1Thromb Res. 19(4-5):695–699. doi: 10.1016/0049-3848(80)90041-9. [DOI] [PubMed] [Google Scholar]
- Flear C. T., Gill G. V., Burn J. Hyponatraemia: mechanisms and management. Lancet. 1981 Jul 4;2(8236):26–31. doi: 10.1016/s0140-6736(81)90261-0. [DOI] [PubMed] [Google Scholar]
- Gibson D. P., DeGowin R. L., Knapp S. A. Effect of X irradiation on release of prostaglandin E from marrow stromal cells in culture. Radiat Res. 1982 Mar;89(3):537–545. [PubMed] [Google Scholar]
- Honn K. V., Busse W. D., Sloane B. F. Prostacyclin and thromboxanes. Implications for their role in tumor cell metastasis. Biochem Pharmacol. 1983 Jan 1;32(1):1–11. doi: 10.1016/0006-2952(83)90644-5. [DOI] [PubMed] [Google Scholar]
- Honn K. V., Romine M., Skoff A. Prostaglandin analogs as inhibitors of tumor cell DNA synthesis. Proc Soc Exp Biol Med. 1981 Apr;166(4):562–567. doi: 10.3181/00379727-166-41109. [DOI] [PubMed] [Google Scholar]
- Jaffe B. M. Prostaglandins and cancer: an update. Prostaglandins. 1974 Jun 25;6(6):453–461. doi: 10.1016/s0090-6980(74)80055-9. [DOI] [PubMed] [Google Scholar]
- Kaliman J., Sinzinger H., Staudacher M., Mannheimer E. Defekte im Prostaglandinsystem. II. Familiärer Plättchen-Prostacyclin-Rezeptor-Defekt (Defekt Wien-Hietzing)--pathogenetische Bedeutung für (frühzeitige) Entstehung der Atherosklerose? Wien Klin Wochenschr. 1985 Mar 29;97(7):323–326. [PubMed] [Google Scholar]
- Lifshitz S., Savage J. E., Taylor K. A., Tewfik H. H., Van Orden D. E. Plasma prostaglandin levels in radiation-induced enteritis. Int J Radiat Oncol Biol Phys. 1982 Feb;8(2):275–277. doi: 10.1016/0360-3016(82)90527-2. [DOI] [PubMed] [Google Scholar]
- Mehta J., Mehta P. Role of blood platelets and prostaglandins in coronary artery disease. Am J Cardiol. 1981 Aug;48(2):366–373. doi: 10.1016/0002-9149(81)90622-6. [DOI] [PubMed] [Google Scholar]
- Moncada S., Gryglewski R., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976 Oct 21;263(5579):663–665. doi: 10.1038/263663a0. [DOI] [PubMed] [Google Scholar]
- Petry F. M., Tutton P. J., Barkla D. H. The influence of arachidonic acid metabolites on cell division in the intestinal epithelium and in colonic tumors. Prostaglandins Leukot Med. 1984 Sep;15(3):349–358. doi: 10.1016/0262-1746(84)90134-3. [DOI] [PubMed] [Google Scholar]
- Reinhold H. S., Buisman G. H. Radiosensitivity of capillary endothelium. Br J Radiol. 1973 Jan;46(541):54–57. doi: 10.1259/0007-1285-46-541-54. [DOI] [PubMed] [Google Scholar]
- Remuzzi G., Misiani R., Marchesi D., Livio M., Mecca G., de Gaetano G., Donati M. B. Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet. 1978 Oct 21;2(8095):871–872. doi: 10.1016/s0140-6736(78)91573-8. [DOI] [PubMed] [Google Scholar]
- Santoro M. G., Philpott G. W., Jaffe B. M. Dose dependent inhibition of B-16 melanoma growth in vivo by a synthetic analogue of PGE2. Prostaglandins. 1977 Oct;14(4):645–651. doi: 10.1016/0090-6980(77)90191-5. [DOI] [PubMed] [Google Scholar]
- Silberbauer K., Sinzinger H., Feigl W., Leithner Ch. Arterielle Strahlenschädigungen. Vasa. 1977;6(2):183–185. [PubMed] [Google Scholar]
- Sinzinger H., Firbas W., Cromwell M. Radiation induced alterations in rabbit aortic prostacyclin formation. Prostaglandins. 1982 Sep;24(3):323–329. doi: 10.1016/0090-6980(82)90159-9. [DOI] [PubMed] [Google Scholar]
- Sinzinger H., Firbas W., Cromwell M. Strahlenvaskulopathie--bedingt durch Anderung der gefässeigenen Prostazyklinsynthese? Wien Klin Wochenschr. 1983 Nov 11;95(21):761–765. [PubMed] [Google Scholar]
- Sinzinger H., Firbas W. Irradiation depresses prostacyclin generation upon stimulation with the platelet-derived growth factor. Br J Radiol. 1985 Oct;58(694):1023–1026. doi: 10.1259/0007-1285-58-694-1023. [DOI] [PubMed] [Google Scholar]
- Sinzinger H., Fitscha P., Peskar B. A. Defekte im Prostaglandinsystem. V. Vererbte (?) Störung des Prostazyklinabbaus im Plasma (Defekt Wien-Döbling). Wien Klin Wochenschr. 1985 Sep 27;97(18):726–729. [PubMed] [Google Scholar]
